LAVA Therapeutics N.V. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
REDMILE GROUP, LLC | 02/14/2025 | 2.07 M | $1.97 M | 0.00% | 7.73% |
SANOFI | 02/14/2025 | 1.92 M | $1.83 M | 100.00% | 7.15% |
MERCK & CO., INC. | 02/14/2025 | 1.15 M | $1.09 M | 100.00% | 4.28% |
BRUCE & CO., INC. | 02/11/2025 | 771,874 | $733,280 | 0.00% | 2.88% |
SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 126,328 | $120,138 | -13.74% | 0.47% |
PATHWAY FINANCIAL ADVISORS LLC | 01/31/2025 | 102,500 | $97,478 | 0.00% | 0.38% |
PNC FINANCIAL SERVICES GROUP, INC. | 02/07/2025 | 65,000 | $61,815 | 0.00% | 0.24% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 48,772 | $46,382 | -52.54% | 0.18% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 41,800 | $39,752 | 100.00% | 0.16% |
ENGINEERS GATE MANAGER LP | 02/14/2025 | 31,985 | $30,418 | 169.01% | 0.12% |
02/14/2025 | 21,508 | $20,454 | 100.00% | 0.08% | |
VIRTU FINANCIAL LLC | 02/11/2025 | 19,916 | $19,000 | 4.26% | 0.07% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 19,604 | $18,643 | 62.51% | 0.07% |
UBS GROUP AG | 02/14/2025 | 18,431 | $17,528 | 1,619.31% | 0.07% |
HRT FINANCIAL LP | 02/14/2025 | 17,836 | $16,000 | 100.00% | 0.07% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 16,164 | $15,371 | 45.31% | 0.06% |
TWO SIGMA SECURITIES, LLC | 02/14/2025 | 13,157 | $12,512 | 100.00% | 0.05% |
CIBC PRIVATE WEALTH GROUP, LLC | 02/12/2025 | 6,000 | $6,120 | 0.00% | 0.02% |
02/06/2025 | 300 | $285 | 100.00% | 0.00% | |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/11/2025 | 20 | $19 | 100.00% | 0.00% |
TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
ALPHA WAVE GLOBAL, LP | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
WALLEYE CAPITAL LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
TSFG, LLC | 01/13/2025 | 0 | $0 | -100.00% | 0.00% |
LAVA Therapeutics N.V. institutional Ownership - FAQ's
During the previous two years, 28 institutional investors and hedge funds held shares of LAVA Therapeutics N.V.. The most heavily invested institutionals were:
Redmile Group, LLC: 2.07 M
Sanofi: 1.92 M
Merck & Co., Inc.: 1.15 M
Bruce & Co., Inc.: 771,874
SPHERA FUNDS MANAGEMENT LTD.: 126,328
Pathway Financial Advisors LLC: 102,500
24.11% of LAVA Therapeutics N.V. stock is owned by institutional investors.
Institutional investors have bought a total of 6.50 M shares in the last 24 months. This purchase volume represents approximately $7.02 M in transactions.